HOXD11 and breast carcinoma: This observation was further validated in 2,436 tissue samples from GTEx and 605 patients with breast cancer (see Methods) from The Cancer Genome Atlas (Pereira et al., 2016) where HOXC11 had the most significant positive correlation and HOXD11 had the most significant negative correlation (Figures 6B and S7D).